Breathe Well Live Well
|
New Data From GAP Landmark Trial Confirm GRAZAX® Prevents Asthma Symptoms in Children
PR Newswire (press release) The data, presented at the 2016 Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) in Vienna, confirm that GRAZAX® can prevent asthma symptoms, as well as offering sustained relief from grass allergy symptoms. |
View full post on asthma – Google News
|
New Data From GAP Landmark Trial Confirm GRAZAX® Prevents Asthma Symptoms in Children
PR Newswire UK (press release) ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today presented new data from the GRAZAX® Asthma Prevention (GAP) trial with GRAZAX®, ALK's allergy immunotherapy tablet against grass pollen allergy. The data, presented at the 2016 Annual Congress … |
View full post on asthma – Google News
|
Pipeline of Asthma Market Covering 129 Companies Reviewed for H1 2016 in New Research Report
PR Newswire (press release) RnRMarketResearch.com adds "Asthma – Pipeline Review, H1 2016" market research report with comparative analysis of Asthma therapy at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) … |
View full post on asthma – Google News
|
Allergy & Asthma Network to Advocate for Patients, Access to Care Innovations at Annual Capitol Hill Day on May 12
PR Newswire (press release) VIENNA, Va., April 25, 2016 /PRNewswire-USNewswire/ — Allergy & Asthma Network will head to Capitol Hill on Thursday, May 12 to advocate for patients and urge Congress to take action on key legislative issues including telehealth services and school … AAFA's asthma & allergy friendly(TM) Certification Program Celebrates 10 Successful Years |
View full post on asthma – Google News
KMBC Kansas City |
Doctor On Demand, Allergy & Asthma Network Team Up To Make Treating Asthma and Allergies Easier for Millions
PR Newswire (press release) SAN FRANCISCO, April 20, 2016 /PRNewswire-USNewswire/ — Today Doctor On Demand, the leading U.S. video medicine provider, announced a new partnership with Allergy & Asthma Network to improve allergy and asthma care for its members. Doctor … Northwestern Medicine develops new technology to treat allergies, asthma Spring Asthma & Allergy Tips 5 tips to breathe easy this spring |
View full post on asthma – Google News
|
Asthma Therapeutics in Asia-Pacific Markets to 2021 – High Prevalence and Launch of Late-Stage Biologics will Drive …
PR Newswire (press release) Asthma is a common chronic inflammatory disease of the airways, characterized by recurrent attacks of breathlessness and wheezing, which vary in frequency and severity from patient to patient. The exact causes of asthma are currently unknown, and may … |
View full post on asthma – Google News
|
New Survey: People Living with Asthma Believe It Is Controlled, But Persistent Symptoms and Limits
PR Newswire (press release) VIENNA, Va., and RIDGEFIELD, Conn., April 7, 2016 /PRNewswire-USNewswire/ — A new survey of people living with asthma reveals they may be accepting persistent symptoms and limits to their everyday activities because they believe their asthma is … |
View full post on asthma – Google News
|
SPIRIVA RESPIMAT Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents
PR Newswire (press release) RIDGEFIELD, Conn., Feb. 3, 2016 /PRNewswire/ — Boehringer Ingelheim Pharmaceuticals, Inc. today announced that SPIRIVA RESPIMAT is now available by prescription for the treatment of asthma in U.S. pharmacies. The U.S. Food and Drug … |
View full post on asthma – Google News
|
Market Access Impact: Asthma/COPD (EU5)
PR Newswire (press release) FirstView's Market Access Impact in Asthma/COPD report takes an in-depth look at the way barriers affect asthma/COPD prescribing, and reveals which brands are winning and losing market share because of it. See what brands are included in this report |
View full post on asthma – Google News
|
Market Access Impact: Asthma/COPD (US)
PR Newswire (press release) FirstView's Market Access Impact in Asthma/COPD report takes an in-depth look at the way barriers affect asthma/COPD prescribing, and reveals which brands are winning and losing market share because of it. See what brands are included in this report |
View full post on asthma – Google News